Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Overholser

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Cardiovascular Medicine|January 2, 2023
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancerElizabeth J Rowe, Tyler Shugg, Reynold C Ly, et al.
Journal of Clinical Pharmacology|November 3, 2011
Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunctionJames E Tisdale, Brian R Overholser, Heather A Wroblewski, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 7, 2016
1-Alpha, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10Xiaoliang Wang, Hongwei Wang, Bing Shen, et al.
Journal of Cardiac Failure|June 28, 2020
Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection FractionJames E Tisdale, Heather A Jaynes, Brian R Overholser, et al.
Clinical and Translational Medicine|October 28, 2021
The CYP3A5 genotypes of both liver transplant recipients and donors influence the time-dependent recovery of tacrolimus clearance during the early stage following transplantationLi Huang, Abdullah A Assiri, Peihao Wen, et al.
Pharmacotherapy|May 15, 2025
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populationsAditi Shendre, Xiaofu Liu, ChienWei Chiang, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Cardiovascular Medicine|January 2, 2023
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancerElizabeth J Rowe, Tyler Shugg, Reynold C Ly, et al.
Journal of Clinical Pharmacology|November 3, 2011
Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunctionJames E Tisdale, Brian R Overholser, Heather A Wroblewski, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 7, 2016
1-Alpha, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10Xiaoliang Wang, Hongwei Wang, Bing Shen, et al.
Journal of Cardiac Failure|June 28, 2020
Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection FractionJames E Tisdale, Heather A Jaynes, Brian R Overholser, et al.
Clinical and Translational Medicine|October 28, 2021
The CYP3A5 genotypes of both liver transplant recipients and donors influence the time-dependent recovery of tacrolimus clearance during the early stage following transplantationLi Huang, Abdullah A Assiri, Peihao Wen, et al.
Pharmacotherapy|May 15, 2025
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populationsAditi Shendre, Xiaofu Liu, ChienWei Chiang, et al.
Pageof 6